**Core Concept**
Diethylstilbestrol (DES) is a synthetic estrogen that was historically prescribed to pregnant women to prevent miscarriage, premature labor, and related complications. However, its use has been associated with severe health consequences, particularly in the offspring of women who took DES during pregnancy. This is a classic example of an endocrine disruptor, which can interfere with the normal development and function of the reproductive system.

**Why the Correct Answer is Right**
The increased risk of cancer in the progeny of women who took DES during pregnancy is primarily due to its effects on the reproductive system. DES is a potent estrogen that can bind to estrogen receptors and alter the normal development of the female reproductive tract, including the vagina, cervix, and uterus. This can lead to the formation of clear cell adenocarcinoma, a rare but aggressive type of cancer that typically affects the vagina or cervix in young women. The exact mechanism of DES-induced cancer is not fully understood, but it is thought to involve the disruption of normal cellular differentiation and the promotion of abnormal cell growth.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not a cancer type associated with DES exposure. Clear cell adenocarcinoma is the primary cancer risk, not squamous cell carcinoma.
**Option B:** This option is incorrect because DES exposure is not primarily associated with an increased risk of breast cancer, although some studies have suggested a possible link. The primary concern is the risk of clear cell adenocarcinoma of the vagina or cervix.
**Option C:** This option is not a cancer type associated with DES exposure. Ovarian cancer is not a known risk of DES exposure, although some studies have suggested a possible link to other reproductive cancers.

**Clinical Pearl / High-Yield Fact**
DES exposure in utero is a classic example of an endocrine disruptor, which can have severe and long-lasting effects on the reproductive system. This highlights the importance of carefully evaluating the risks and benefits of hormone therapy during pregnancy and the need for rigorous monitoring and follow-up to detect potential health consequences.

**Correct Answer: D. Clear cell adenocarcinoma**